What You Should Know: - VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, has just announced the completion of an investment funded by Health Insight Capital, the investment arm of HCA Healthcare Inc., (NYSE: HCA), one of the nation’s leading healthcare providers. - The investment will go toward further accelerating VitalConnect’s rapidly growing cardiac monitoring business segment while advancing key Remote Patient Monitoring of individuals who
Read More
Biosensors in Healthcare | Devices | Analytics | News, Analysis, Insights
New Hospital-At-Home Study Focuses on Rural Health Deserts
What You Should Know: - Appalachian Regional Healthcare (ARH), based in Lexington, Ky., will use Biofourmis’ virtual care and AI-based predictive analytics technology to support a new Rural Home Hospital program delivering acute hospital-level care inside patients’ homes--including a clinical trial studying this care model in rural areas. - ARH joins Blessing Health System—which is also using Biofourmis’ solution—as one of only two U.S. participants
Read More
Powered by Biofourmis, Blessing Health System Partners Launches Home Hospital Services
What You Should Know: - Blessing Health System, an integrated rural health system selects Biofourmis, a virtual care and digital therapeutics provider to launch its own home hospital services. - As part of the selection, Biofourmis is supporting the health system with its turnkey, end-to-end, home hospital solution for participation in the Rural Home Hospital project. Delivering Acute-Level Hospital Care Inside Patients’ Homes This new program allows caregivers to
Read More
physIQ, CellCarta Collaborate on Study to Revolutionize Vaccine
What You Should Know: - Today, digital medicine leader physIQ and CellCarta, a global leader in precision medicine services announced they are collaborating on a groundbreaking study that could revolutionize vaccine development. - The strategic collaboration advances the detailed study of early, individualized human responses to vaccinations as pharma companies race to deliver safe, effective vaccines sooner. physIQ, a pioneer in digital medicine, and CellCarta, a global leader in
Read More
Cipher Skin Lands $5M for Mesh Network of Sensors to Capture Movement
What You Should Know: - Denver-based data startup, Cipher Skin, today announced its $5 million Series A, led by the Boyett Group with participation from Draper Capital, Tribe Capital and TKC Capital to grow its product line and expand into new markets. - Founded in 2017, Cipher Skin’s first-of-its-kind, patented, sensor technology, Cipher Mesh, wraps around patients’ body parts—allowing doctors, PTs, and human performance professionals to collect detailed data of the body in motion
Read More
3 Steps to Maintain Telehealth’s Momentum Post-Pandemic
In the face of COVID-19, healthcare witnessed how crises can become the long-awaited push for creativity and innovation that the industry needs. When our healthcare infrastructure’s weaknesses were exposed, telehealth helped to stitch them up, with the number of telehealth claims increasing 8,336% nationally from April 2019 to April 2020. Out of need, patients quickly turned to telehealth as a new model of care delivery; clinicians adapted to a new avenue for engaging with patients, policymakers
Read More
Brigham, Biofourmis Co-Develops Tech Solution to Enable Home Hospital Care
What You Should Know: - Brigham is working with Biofourmis on a national
rollout of their co-developed technology solution, which has been refined and
scaled for use by other healthcare systems across the country seeking to
establish and execute similar home hospital programs to alleviate COVID-related
capacity issues and to receive 1:1 parity on payments from CMS. - The Hospital@HomeTM platform provides a turnkey,
end-to-end ecosystem for any health system that wants to quickly launch
Read More
NIH Taps PhysIQ to Develop AI-Based COVID-19 Digital Biomarker
What You Should Know: - physIQ has been selected by the National Institute of Health (NIH) to develop an innovative AI-based COVID-19 digital biomarker solution to address the COVID-19 pandemic. - Early detection of COVID-19 decompensation in patients
is complicated by infrequent and non-specific clinical data. The first-in-kind
tool will collect and analyzes continuous physiologic data could provide early
clinical indicators of COVID-19 decompensation. The National Cancer
Institute
Read More
HHS Launches $1.5M Second Phase of KidneyX Prize Competition to Redesign Dialysis
- KidneyX launches the $1.5 million second phase of the Redesign Dialysis prize competition.- Redesign Dialysis Phase 2 seeks prototype solutions or components of solutions, that can replicate normal kidney functions or improve dialysis access.- The competition calls on researchers, innovators, patients, and investors with expertise in nephrology, biotechnology, bioengineering, and medical devices to submit solutions.The U.S. Department of Health and Human Services (HHS) and the American Society
Read More
Research: Microneedle Biosensors Accurately Detect Patient’s Antibiotic Levels in Real-Time
- Researchers find microneedle biosensors can be used to monitor the changing concentration of antibiotics in a patient’s system. - Findings published in The Lancet Digital Health, show the sensors enable real-time monitoring of changes in antibiotic concentration in the body, with similar results to those obtained from blood tests. Small, non-invasive patches worn on the skin can accurately detect the levels of medication in a patient's system, matching the accuracy of current
Read More
